This last version is the only one that has ever been licenced for human use, although its use is now discontinued
The plotter might help you have a more informed conversation, but it does not replace clinical assessment
Key timing considerations: Broader Tmax window (8 to 72 hours) means less precision in predicting peak effects Dual GIP/GLP-1 mechanism may produce a different side effect timing pattern than pure GLP-1 agonists Body aches and muscle pain may peak later than GI symptoms, around 24 to 48 hours post-injection Consider how tirzepatide affects metabolism throughout the weekly cycle The appetite suppression timeline may differ from semaglutide due to the dual mechanism Dose escalation timing: Tirzepatide starts at 2.5mg weekly, escalating to 5mg after 4 weeks
doi: 10.1158/1541-7786.MCR-05-0106 116 LeungWKToKFGoMYChanKKChanFKNgEKet al
Some of the most discussed being Alzheimers disease, Parkinsons disease, liver disease, cancer, heart attacks, seizures, and diabetes